Takeda's Response to COVID-19 If you were diagnosed with COVID-19 and have recovered, you may be able to help in furthering research into a potential therapy for others by donating your plasma.

Guided Search

Enter the condition you are interested in

Next

Find a Trial

Click for Guided SearchOpen Guided Search
Condition or Trial Identifier
Location

FILTERS

FILTERS (1)

Clear all

FILTERS (1)

Clear all
Medical Condition / Disease  
Drug / Treatment  
Trial Status  
Age

or Select Age Range:

Trial Type  
Phase  
Trial Identifier  
Results  
Show Results

Results

(1863)
Selected Filters
United Statesfalse
Recruiting
All Ages

Hemophilia B

RIXUBIS PMS India (RIXUBIS PMS)
8,401 miles (13,520 km) from
United States
All Ages years
Recruiting
From 12 years

Hemophilia A

ADYNOVATE Drug Use-Results Survey
5,643 miles (9,081 km) from
United States
From 12 years
Recruiting
From 18 years

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
179 miles (287 km) from
United States
From 18 years
Recruiting
From 18 years

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP
1,001 miles (1,611 km) from
United States
From 18 years
Recruiting
From 18 years

Acquired Hemophilia A

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
684 miles (1,100 km) from
United States
From 18 years
Recruiting
Up to 5 years

Hemophilia A

Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Recombinant FVIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years of Age With Severe Hemophilia A
450 miles (724 km) from
United States
Up to 5 years
Recruiting
All Ages

Hemophilia A

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
974 miles (1,568 km) from
United States
All Ages years
Recruiting
18 - 65 years

Hemophilia A or B With Inhibitors

FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)
5,273 miles (8,485 km) from
United States
18 - 65 years
Recruiting
Up to 70 years

Congenital thrombotic thrombocytopenic purpura

A Study of Prophylactic and On-demand Treatment of Congenital Thrombotic Thrombocytopenic Purpura (cTTP) With BAX 930 (rADAMTS13)
271 miles (436 km) from
United States
Up to 70 years
Recruiting
All Ages

Hemophilia A

A Post Marketing Surveillance Study for ADYNOVATE in South Korea
6,400 miles (10,300 km) from
United States
All Ages years